
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
London-The board of Drew Scientific Group PLC, a diagnostics company specializing in the design, manufacture, sale, and distribution of analytical systems for laboratory testing, has rejected Escalon Medical Corp.'s offer to trade its stock for Drew shares.




